[1] 杨方集,彭亮,刘月英,等.2016年肝衰竭诊治进展.中华肝脏病杂志,2017,25:94-99. [2] Olson,Jody C.Acute-on-chronic and Decompensated Chronic Liver Failure:Definitions,Epidemiology,and Prognostication.Crit Care Clin,2016,32:301-309. [3] Cheung A,Tanna S,Ison MG.Infectious Complications in Critically Ill Liver Failure Patients.Semin Respir Crit Care Med,2018,39:578-587. [4] Yang L,Wu T,Li J.Bacterial Infections in Acute-on-Chronic Liver Failure.Semin Liver Dis,2018,38:121-133. [5] 中华医学会感染病学分会肝衰竭与人工肝组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊疗指南.现代医药卫生,2018,34:3897-3904. [6] Mobley CM,Saharia A.Management of the critically ill liver failure patient: surpassing our limitations to reach transplantation.Curr Opin Organ Transplant,2018, 23:145-150. [7] Shalimar,Rout G,Jadaun SS,et al.Prevalence,predictors and impact of bacterial infection in acute on chronic liver failure patients.Dig Liver Dis,2018,50:1225-1231. [8] 曹竹君,谢青.慢加急性肝衰竭患者的感染问题:发生、特征及其对疾病进展和预后的影响.中华肝脏病杂志,2018,26:6-9. [9] Mücke,Marcus M,Rumyantseva T,et al.Bacterial infection-triggered acute-on-chronic liver failure is associated with increased mortality.Liver Int,2017,12:3218-3221. [10] Chen RC,Wang XD,Dong JZ,et al.A MELD-based nomogram for predicting 3-month mortality of patients with acute-on-chronic hepatitis B liver failure.Clin Chim Acta,2017,468:195-200. [11] Cai J,Zhang M,Han T,et al.Characteristics of infection and its impact on short term outcome in patients with acute-on-chronic liver failure.Medicine (Baltimore),2017,96:e8057. [12] Neong SF,Adebayo D,Wong F.An update on the pathogenesis and clinical management of cirrhosis with refractory ascites.Expert Rev Gastroenterol Hepatol,2019,13:293-305. [13] Solà E,Solé C,Ginès P.Management of uninfected and infected ascites in cirrhosis,Liver Int,2016,36:109-115. [14] Merli M,Riggio O.Interaction between infection and hepatic encephalopathy.J Hepatol,2015,62:746-747. [15] Piotrowski D,Bor-Kaczmarska A.Bacterial infections and hepatic encephalopathy in liver cirrhosis-prophylaxis and treatment.Adv Med Sci,2017, 62:345-356. [16] Barreto R,Fagundes C,Guevara M,et al.Type-1 hepatorenal syndrome associated with infections in cirrhosis: natural history,outcome of kidney function,and survival.Hepatology,2014,59:1505-1513. [17] Godinjak A,Iglica A,Rama A,et al.Predictive value of SAPS II and APACHE II scoring systems for patient outcome in a medical intensive care unit.Acta Med Acad,2016,45:97-103. |